ArticleTH open : companion journal to thrombosis and haemostasis2026
Combined Effect of Hemoglobin Levels and Obesity on the Risk of Incident Venous Thromboembolism: The Tromsø Study.
Article in TH open : companion journal to thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Red blood cells (RBCs) are key determinants of blood viscosity, which is related to thrombosis risk. Obesity is a well-recognized risk factor for venous thromboembolism (VTE). Whether the combination of these two risk factors synergistically increases VTE risk has not been studied. We aimed to investigate the joint effect of high hemoglobin and obesity on the risk of VTE in a population-based cohort. Methods: We included 35,801 participants from the Tromsø 4-7 surveys (1994-2016). All first-lifetime VTEs were validated and recorded from enrollment throughout 2020. Hemoglobin levels were categorized as low (women: <13.2 g/dL, men: <14.7 g/dL), medium (women: 13.2-14.0 g/dL, men: 14.7-15.5 g/dL), and high (women: ≥14.1 g/dL, men: ≥15.6 g/dL). Body mass index (BMI) was categorized as normal weight (<25 kg/m Results: During 17.3 years of median follow-up, 1,040 cases of VTE occurred. In normal weight individuals, the HR of VTE according to high hemoglobin levels was 1.22 (95% CI: 0.90-1.66). The HR of VTE in obese individuals with low hemoglobin was 1.81 (95% CI: 1.35-2.43), while the HR of VTE in obese individuals with high hemoglobin levels was 1.71 (95% CI: 1.30-2.25), compared with those with normal weight and low hemoglobin. Conclusion: Combination of high hemoglobin and obesity did not yield excess VTE risk, suggesting no evidence of biological interaction between these factors in the pathogenesis of VTE.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.